Tor Biering-sørensen

This large study aims to find out how well the Abrysvo RSV vaccine works at preventing hospitalizations caused by RSV in adults. It will enroll 690,000 adults aged 18 and older. Participants will be randomly assigned to either receive the vaccine or not, and researchers will trac…

This large study in Denmark is testing whether a special alert system in heart devices can help manage heart failure better. Over 1,400 patients with implanted heart devices will be randomly assigned to either have their care guided by remote alerts from the device or to receive …

This large Danish study is testing whether two common nutritional supplements—coenzyme Q10 and selenium—can help people with heart failure. About 4,000 participants will take these supplements or placebo pills for 2-3 years to see if they reduce hospital stays or death from heart…

This large study aims to see how well an updated COVID-19 vaccine prevents severe illness in healthy adults aged 50-64. About 285,000 participants without known risk factors will be randomly assigned to receive either the vaccine or no vaccine. Researchers will track hospital vis…